Aug 23 (Reuters) - The U.S. Food and Drug Administration

on Friday classified a recall of Inari Medical's ( NARI )

ClotTriever catheter that helps capture and remove large clot

from big vessels as "most serious".

The affected products include all devices and lot numbers

with labeled dates prior to Aug. 1, 2024, whose use might cause

serious adverse health consequences, including device

entrapment, vessel damage, and/or blockage of lung arteries and

death, the FDA said.

There have been four reported injuries and six reports of

death, according to the statement by the health regulator.

(Reporting by Savyata Mishra in Bengaluru; Editing by Arun

Koyyur)